The veterinary blood glucose monitoring market involves testing tools like glucometers, test strips, and lancets that help in measuring blood glucose levels in veterinary patients. Glucose monitoring devices help veterinarians efficiently diagnose and manage diabetes in pets. Point-of-care blood glucose meters offer quick results within 5-10 seconds and are easy-to-use. Veterinary clinics and pet owners widely rely on glucose monitors to maintain optimal glucose levels in diabetic cats and dogs through insulin therapy and diet control. 

The Global veterinary blood glucose market is estimated to be valued at US$ 530.27 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the veterinary Blood Glucose Monitoring Market Size are IBM Corporation (IBM Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., Insitro, and among others. The increasing pet healthcare expenditure and growing pet insurance purchase are fueling the demand for glucose test strips and monitors. Diabetes is a common disease affecting nearly 1 in 200 dogs and 1 in 500 cats. With rising pet ownership and humanization of pets, more owners are willing to spend on diabetes management of their furry friends.

The growing awareness about animal health and increasing focus on pain-free pet care is driving the global expansion of the veterinary blood glucose monitoring market. More veterinary clinics and hospitals are adopting POC glucose monitors for efficient diabetes diagnosis and maintaining glucose records. Manufacturers are also launching low-cost glucose test strips and monitors for veterinary use to tap market opportunities in developing nations.
Get more insights on Blood Glucose Monitoring Market